




Haochen Zhang
26 posts







1/n Now published in @NatureMedicine : The phase 2 #POLAR trial of pembrolizumab + olaparib maintenance in metastatic pancreatic cancer. @CpcrMsk @MSKCancerCenter @MSK_DeptOfMed @PICIatMSK rdcu.be/e9WmJ

Development and Validation of a Computational Histology Artificial Intelligence–Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer. Co-authored by @haochenz39, @tjroycemd, @DrHendifar, & @graokane. Read the full article. bit.ly/4r2SGDv #pamcsm




New @NatureGenet paper by @ciacobu @MSKCancerCenter on genomic evolution of #PancreaticCancer at single cell resolution. Genomic heterogeneity of KRAS allelic balance likely explains a lot of de novo heterogeneity in response to KRAS inhibitors. nature.com/articles/s4158…



Nature retracts paper for data manipulation by Ph.D. student. retractionwatch.com/2026/01/14/nat…




New preprint from @ciacobu @CpcrMsk Genomic evolution of #PancreaticCancer at single-cell resolution biorxiv.org/content/10.110… @EileenMOReilly @CentralParkWMD @benjraphael This study sequenced 137,491 single-nucleus DNA libraries from 24 pancreatic cancers, including primary tumors, metastatic cancers from rapid autopsy samples, and longitudinal samples from patients who had recurrence. Incredible dataset mapping evolutionary trajectories in this cancer.














